HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1,2,3-trieicosapentaenoyl glycerol

Also Known As:

EPA-TG

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Glycerides: 109
  - Triglycerides: 40895
    - 1,2,3-trieicosapentaenoyl glycerol: 2

Experts

1.	Ding, Lin: 1 article (07/2019)
2.	Shi, Hao-Hao: 1 article (07/2019)
3.	Wang, Yu-Ming: 1 article (07/2019)
4.	Xu, Jie: 1 article (07/2019)
5.	Xue, Chang-Hu: 1 article (07/2019)
6.	Zhang, Ling-Yu: 1 article (07/2019)
7.	Zhang, Tian-Tian: 1 article (07/2019)

Related Diseases

1.	Atherosclerosis 07/17/2019 - "Compared with the model group, a decrease in the area of atherosclerosis lesions at the aorta was observed in both EPA-treated groups, in which EPA-PL was superior to EPA-TG. "
2.	Thrombosis (Thrombus) 12/01/1986 - "Our results suggest that an EPA-TG emulsion is applicable to those patients who need both intravenous alimentation and preventive care of thrombosis, such as postoperative patients."
3.	Inflammation (Inflammations) 07/17/2019 - "In conclusion, EPA-PL was superior to EPA-TG in reducing lesion progression by modulating the hepatic lipid metabolism, as well as decreasing the inflammation in the artery wall and circulatory system, which might be attributed to their structural differences at the sn-3 position." 07/17/2019 - "In addition, EPA-PL and EPA-TG suppressed the inflammation markers in the aorta and circulation. "

Related Drugs and Biologics

1.	Emulsions